An additional report has suggested that MYCN amplified cell lines are more sensitive to ATR inhibition, in this case employing AZD6738, and demonstrated sensitivity in a Th-MYCN-driven mouse NB model61. The gene discussed is ATR; the disease is neuroblastoma.